Akiko Morinaga

Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial

Keiko Imamura, Yuishin Izumi, Makiko Nagai et al. · EClinicalMedicine · 2022 · 53 citations · Full text

Medicine, Neurology, Pharmacology +16

Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients

Keiko Imamura, Yuishin Izumi, Haruhiko Banno et al. · BMJ Open · 2019 · 48 citations · Full text

Medicine, Neurology, Pharmacology +17

Peptide Vaccination for Patients With Melanoma and Other Types of Cancer Based on Pre-existing Peptide-Specific Cytotoxic T-Lymphocyte Precursors in the Periphery

Shoko Tanaka, Mamoru Harada, Takashi Mine et al. · Journal of Immunotherapy · 2003 · 41 citations

Medicine, Immunology, Oncology +17

Immunological monitoring during combination of patient‐oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer

Masanori Noguchi, Kyogo Itoh, Shigetaka Suekane et al. · The Prostate · 2004 · 27 citations

Medicine, Immunology, Oncology +17

Association between pulse pressure and progression of chronic kidney disease

Toshiki Maeda, Soichiro Yokota, Takumi Nishi et al. · Scientific Reports · 2021 · 13 citations · Full text

Medicine, Biostatistics, Nephrology +15